Literature DB >> 35130028

How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study.

Nella Junna1, Sanni Ruotsalainen1, Elisabeth Widén1, Ida Surakka1,2, Nina Mars1, Pietari Ripatti1, Juulia J Partanen1, Johanna Aro1, Pekka Mustonen3, Tiinamaija Tuomi1,4,5,6, Aarno Palotie1,7, Veikko Salomaa8, Jaakko Kaprio1, Jukka Partanen9, Kristina Hotakainen10, Pasi Pöllänen11,12, Samuli Ripatti1,13,7.   

Abstract

BACKGROUND: Prediction tools that combine polygenic risk scores with clinical factors provide a new opportunity for improved prediction and prevention of atherosclerotic cardiovascular disease, but the clinical utility of polygenic risk score has remained unclear.
METHODS: We collected a prospective cohort of 7342 individuals (64% women, mean age 56 years) and estimated their 10-year risk for atherosclerotic cardiovascular disease both by a traditional risk score and a composite score combining the effect of a polygenic risk score and clinical risk factors. We then tested how returning the personal risk information with an interactive web-tool impacted on the participants' health behavior.
RESULTS: When reassessed after 1.5 years by a clinical visit and questionnaires, 20.8% of individuals at high (>10%) 10-year atherosclerotic cardiovascular disease risk had seen a doctor, 12.4% reported weight loss, 14.2% of smokers had quit smoking, and 15.4% had signed up for health coaching online. Altogether, 42.6% of persons at high risk had made one or more health behavioral changes versus 33.5% of persons at low/average risk such that higher baseline risk predicted a favorable change (OR [CI], 1.53 [1.37-1.72] for persons at high risk versus the rest, P<0.001), with both high clinical (P<0.001) and genomic risk (OR [CI], 1.10 [1.03-1.17], P=0.003) contributing independently.
CONCLUSIONS: Web-based communication of personal atherosclerotic cardiovascular disease risk-data including polygenic risk to middle-aged persons motivates positive changes in health behavior and the propensity to seek care. It supports integration of genomic information into clinical risk calculators as a feasible approach to enhance disease prevention.

Entities:  

Keywords:  cardiovascular disease; communication; genomics; risk factor; weight loss

Mesh:

Year:  2022        PMID: 35130028     DOI: 10.1161/CIRCGEN.121.003459

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN: 2574-8300


  7 in total

1.  Polygenic scores in biomedical research.

Authors:  Iftikhar J Kullo; Cathryn M Lewis; Michael Inouye; Alicia R Martin; Samuli Ripatti; Nilanjan Chatterjee
Journal:  Nat Rev Genet       Date:  2022-03-30       Impact factor: 59.581

2.  Analysis of Clinical Traits Associated With Cardiovascular Health, Genomic Profiles, and Neuroimaging Markers of Brain Health in Adults Without Stroke or Dementia.

Authors:  Julián N Acosta; Cameron P Both; Cyprien Rivier; Natalia Szejko; Audrey C Leasure; Thomas M Gill; Seyedmehdi Payabvash; Kevin N Sheth; Guido J Falcone
Journal:  JAMA Netw Open       Date:  2022-05-02

3.  Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification.

Authors:  Soo-Hwang Teo; Jingmei Li; Mikael Hartman; Peh Joo Ho; Weang Kee Ho; Alexis J Khng; Yen Shing Yeoh; Benita Kiat-Tee Tan; Ern Yu Tan; Geok Hoon Lim; Su-Ming Tan; Veronique Kiak Mien Tan; Cheng-Har Yip; Nur-Aishah Mohd-Taib; Fuh Yong Wong; Elaine Hsuen Lim; Joanne Ngeow; Wen Yee Chay; Lester Chee Hao Leong; Wei Sean Yong; Chin Mui Seah; Siau Wei Tang; Celene Wei Qi Ng; Zhiyan Yan; Jung Ah Lee; Kartini Rahmat; Tania Islam; Tiara Hassan; Mei-Chee Tai; Chiea Chuen Khor; Jian-Min Yuan; Woon-Puay Koh; Xueling Sim; Alison M Dunning; Manjeet K Bolla; Antonis C Antoniou
Journal:  BMC Med       Date:  2022-04-26       Impact factor: 11.150

4.  Reaching for Precision Healthcare in Finland via Use of Genomic Data.

Authors:  Tiina Wahlfors; Birgit Simell; Kati Kristiansson; Sirpa Soini; Terhi Kilpi; Marina Erhola; Markus Perola
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

5.  Inframe insertion and splice site variants in MFGE8 associate with protection against coronary atherosclerosis.

Authors:  Sanni E Ruotsalainen; Ida Surakka; Nina Mars; Juha Karjalainen; Mitja Kurki; Masahiro Kanai; Kristi Krebs; Sarah Graham; Pashupati P Mishra; Binisha H Mishra; Juha Sinisalo; Priit Palta; Terho Lehtimäki; Olli Raitakari; Lili Milani; Yukinori Okada; Aarno Palotie; Elisabeth Widen; Mark J Daly; Samuli Ripatti
Journal:  Commun Biol       Date:  2022-08-17

6.  Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization.

Authors:  Anna C F Lewis; Emma F Perez; Anya E R Prince; Hana R Flaxman; Lizbeth Gomez; Deanna G Brockman; Paulette D Chandler; Benjamin J Kerman; Matthew S Lebo; Jordan W Smoller; Scott T Weiss; Carrie L Blout Zawatksy; James B Meigs; Robert C Green; Jason L Vassy; Elizabeth W Karlson
Journal:  Genome Med       Date:  2022-10-07       Impact factor: 15.266

7.  Impact of polygenic risk communication: an observational mobile application-based coronary artery disease study.

Authors:  Evan D Muse; Shang-Fu Chen; Shuchen Liu; Brianna Fernandez; Brian Schrader; Bhuvan Molparia; André Nicolás León; Raymond Lee; Neha Pubbi; Nolan Mejia; Christina Ren; Ahmed El-Kalliny; Ernesto Prado Montes de Oca; Hector Aguilar; Arjun Ghoshal; Raquel Dias; Doug Evans; Kai-Yu Chen; Yunyue Zhang; Nathan E Wineinger; Emily G Spencer; Eric J Topol; Ali Torkamani
Journal:  NPJ Digit Med       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.